BACKGROUND: Accurate and reliable measurement of leukoaraiosis, or MR-detected white, matter hyper-intensity (WMH) burden in subjects with acute ischemic stroke (AIS) is important for, ongoing research studies and future models of risk and outcome prediction, but the presence of a, cerebral infarct may complicate measurement. We sought to assess accuracy of a volumetric method, designed to measure WMH in AIS subjects as compared to the previously validated protocol. NEW METHOD: We randomly selected and equally sampled 120 brain scans from the Atherosclerosis, Risk in Communities (ARIC) MRI Study individuals within designated mild, moderate, and severe, tertiles of WMH volume (WMHV). T2 FLAIR axial images were analyzed using the AIS WMH volumetric, protocol and compared with the ARIC (gold standard) method. Pearson correlation coefficients, linear, concordance correlation coefficient, and Blant–Altman procedures were used to assess measurement, agreements between the two procedures. RESULTS: Median WMHV determined by using the ARIC method was 7.8 cm3 (IQR 5.7–13.55) vs. 3.54 cm3, (IQR 2.1–7.2) using the AIS WMH method. There was good correlation between the two measurements, (r = 0.52, 0.67, and 0.9 for tertiles 1, 2, and 3 respectively) (p < 0.001). COMPARISON WITH EXISTING METHOD: The AIS WMH protocol was specific for leukoaraiosis in ischemic, stroke, but it appeared to underestimate WMHV compared to the gold standard method. CONCLUSIONS: Estimates of MR-detectable WMH burden using a volumetric protocol designed for, analysis of clinical scans correlate strongly with gold standard measurements. These findings will, facilitate future studies of WMH in normal aging and in patients with stroke and other cerebrovascular, disease.
BACKGROUND: Accurate and reliable measurement of leukoaraiosis, or MR-detected white, matter hyper-intensity (WMH) burden in subjects with acute ischemic stroke (AIS) is important for, ongoing research studies and future models of risk and outcome prediction, but the presence of a, cerebral infarct may complicate measurement. We sought to assess accuracy of a volumetric method, designed to measure WMH in AIS subjects as compared to the previously validated protocol. NEW METHOD: We randomly selected and equally sampled 120 brain scans from the Atherosclerosis, Risk in Communities (ARIC) MRI Study individuals within designated mild, moderate, and severe, tertiles of WMH volume (WMHV). T2 FLAIR axial images were analyzed using the AIS WMH volumetric, protocol and compared with the ARIC (gold standard) method. Pearson correlation coefficients, linear, concordance correlation coefficient, and Blant–Altman procedures were used to assess measurement, agreements between the two procedures. RESULTS: Median WMHV determined by using the ARIC method was 7.8 cm3 (IQR 5.7–13.55) vs. 3.54 cm3, (IQR 2.1–7.2) using the AIS WMH method. There was good correlation between the two measurements, (r = 0.52, 0.67, and 0.9 for tertiles 1, 2, and 3 respectively) (p < 0.001). COMPARISON WITH EXISTING METHOD: The AIS WMH protocol was specific for leukoaraiosis in ischemic, stroke, but it appeared to underestimate WMHV compared to the gold standard method. CONCLUSIONS: Estimates of MR-detectable WMH burden using a volumetric protocol designed for, analysis of clinical scans correlate strongly with gold standard measurements. These findings will, facilitate future studies of WMH in normal aging and in patients with stroke and other cerebrovascular, disease.
Authors: Stefan Skare; Rexford D Newbould; David B Clayton; Gregory W Albers; Scott Nagle; Roland Bammer Journal: Magn Reson Med Date: 2007-05 Impact factor: 4.668
Authors: D S Knopman; A D Penman; D J Catellier; L H Coker; D K Shibata; A R Sharrett; T H Mosley Journal: Neurology Date: 2011-05-04 Impact factor: 9.910
Authors: N S Rost; R M Rahman; A Biffi; E E Smith; A Kanakis; K Fitzpatrick; F Lima; B B Worrall; J F Meschia; R D Brown; T G Brott; A G Sorensen; S M Greenberg; K L Furie; J Rosand Journal: Neurology Date: 2010-11-09 Impact factor: 9.910
Authors: Peter Kochunov; David Glahn; Anderson Winkler; Ravindranath Duggirala; Rene L Olvera; Shelley Cole; Thomas D Dyer; Laura Almasy; Peter T Fox; John Blangero Journal: Stroke Date: 2009-10-15 Impact factor: 7.914
Authors: E M Arsava; R Rahman; J Rosand; J Lu; E E Smith; N S Rost; A B Singhal; M H Lev; K L Furie; W J Koroshetz; A G Sorensen; H Ay Journal: Neurology Date: 2009-04-21 Impact factor: 9.910
Authors: Rebecca F Gottesman; Josef Coresh; Diane J Catellier; A Richey Sharrett; Kathryn M Rose; Laura H Coker; Dean K Shibata; David S Knopman; Clifford R Jack; Thomas H Mosley Journal: Stroke Date: 2009-11-19 Impact factor: 7.914
Authors: Mark R Etherton; Ona Wu; Anne-Katrin Giese; Arne Lauer; Gregoire Boulouis; Brittany Mills; Lisa Cloonan; Kathleen L Donahue; William Copen; Pamela Schaefer; Natalia S Rost Journal: Transl Stroke Res Date: 2019-01-28 Impact factor: 6.829
Authors: Alessandro Biffi; Abbas Rattani; Christopher D Anderson; Alison M Ayres; Edip M Gurol; Steven M Greenberg; Jonathan Rosand; Anand Viswanathan Journal: Brain Date: 2016-08-06 Impact factor: 13.501
Authors: Adam de Havenon; Jennifer J Majersik; David L Tirschwell; J Scott McNally; Gregory Stoddard; Natalia S Rost Journal: Neurology Date: 2019-02-08 Impact factor: 9.910
Authors: M Fareed K Suri; Jincheng Zhou; Ye Qiao; Haitao Chu; Adnan I Qureshi; Tom Mosley; Rebecca F Gottesman; Lisa Wruck; A Richey Sharrett; Alvaro Alonso; Bruce A Wasserman Journal: Neurology Date: 2018-03-09 Impact factor: 9.910
Authors: Ahmed A Bahrani; Charles D Smith; Justin M Barber; Omar M Al-Janabi; David K Powell; Anders H Andersen; Brandon D Ramey; Erin L Abner; Larry B Goldstein; Zachary Winder; Brian T Gold; Linda Van Eldik; Donna M Wilcock; Gregory A Jicha Journal: J Neurosci Methods Date: 2021-06-24 Impact factor: 2.987
Authors: Mark R Etherton; Ona Wu; Pedro Cougo; Svetlana Lorenzano; Hua Li; Lisa Cloonan; Mark J R J Bouts; Arne Lauer; Ken Arai; Eng H Lo; Steve K Feske; Karen L Furie; Natalia S Rost Journal: Stroke Vasc Neurol Date: 2019-09-03